RedHill Biopharma Announces Closing of $35 Million Bought Deal Offering of American Depositary Shares
USA - English
Share this article
Share this article
TEL AVIV, Israel and RALEIGH, N.C., March 4, 2021 /PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ( RedHill or the Company ), a specialty biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 4,375,000 American Depositary Shares (ADSs) of the Company, at a price to the public of $8.00 per ADS. Each ADS represents ten ordinary shares, par value NIS 0.01 per share, of the Company.
H.C. Wainwright & Co. acted as the sole book-running manager for the offering.
Prometheus Biosciences Announces Appointment of Mark Stenhouse as Chief Operating Officer
News provided by
Share this article
Share this article
SAN DIEGO, March 4, 2021 /PRNewswire/ Prometheus Biosciences, Inc. ( Prometheus ), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease (IBD), today announced the appointment of commercial veteran Mark Stenhouse as Chief Operating Officer. Mark s leadership and deep experience with GI diagnostics and therapeutics make him a great fit for Chief Operating Officer, which is a key role as we accelerate our growth, said Mark McKenna, President and CEO of Prometheus. His thirty years of biopharma industry experience, and building and leading successful teams, will strengthen our leadership team as we seek to revolutionize the treatment of IBD with a precision medicine a
CATO SMS Announces Consulting Leadership Appointment
Global Provider Appoints Leslie DeVos to Spearhead Continued Expansion of Consulting Capabilities
News provided by
Share this article
Share this article
CARY, N.C., March 3, 2021 /PRNewswire/ CATO SMS, a global provider of regulatory and clinical research services, announced today that it has appointed Leslie DeVos to president of its consulting business. Ms. DeVos will spearhead the company s continued expansion of its consulting capabilities tailored to the unique needs of small and emerging biopharmaceutical companies.
Biopharmaceutical executive Leslie DeVos will lead consulting for CATO SMS Leslie s extensive regulatory knowledge will help provide our customers with outstanding services and support.
XanEdu s FlexEd courseware is an affordable, proven technology platform that begins with free, OER textbook content and leverages experienced educators to curate enhanced content including video, readings, homework, lecture slides, discussion topics and more. The content within each courseware title is carefully designed to guide students to mastery of each topic; FlexEd instructors regularly achieve 90% course completion rates. FlexEd integrates with any learning management system and provides students with study aids, self-assessments and a personalized learning center with text and email reminders.
Open RN is funded by a grant from the US Department of Education to address the rising costs of textbooks which limit access to education for many students. Open RN textbooks are high quality, peer reviewed material. They contain active learning tools to assist students as they learn challenging concepts and apply them to patient care in the manner in which they will be tested